Recombinant Human Follistatin-like 5/FSTL5 Protein, CF
Recombinant Human Follistatin-like 5/FSTL5 Protein, CF Summary
Product Specifications
Arg21-Ala847, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
9066-FN
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
Recombinant Human Follistatin-like 5/FSTL5 (Catalog # 9066-FN) inhibits Hep3B human hepatocellular carcinoma cell survival. The ED50 for this effect is 3-12 μg/mL.
Reconstitution Calculator
Background: Follistatin-like 5/FSTL5
Follistatin-like 5 (FSTL5) is a secreted 94 kDa (predicted) member of the SPARC protein family (1). In its N-terminal half, FSTL5 contains a Kazal-like domain,
two EF-hand domains, and two Ig-like domains. Mature human FSTL5 shares 91% amino acid sequence identity with mouse and rat FSTL5. Alternative splicing generates an isoform with a 10 residue deletion following the second Ig-like domain. FSTL5 is expressed in the cartilage and tendon of developing digits and the shafts of long bones (2). In the brain it is expressed in the olfactory bulb, CA3 area of the hippocampus, and granule cell layer of the cerebellum (3). FSTL5 inhibits the proliferation and promotes the apoptosis of hepatocellular carcinoma cells (4). Its expression in medulloblastoma and down-regulation in hepatocellular carcinoma are associated with poor prognosis (4, 5).
- Bradshaw, A.D. (2012) Int. J. Biochem. Cell Biol. 44:480.
- Lorda-Diez, C.I. et al. (2013) PLoS One 8:e60423.
- Masuda, T. et al. (2014) Congenit. Anom. (Kyoto) 54:63.
- Zhang, D. et al. (2015) Int. J. Clin. Exp. Pathol. 8:3386.
- Remke, M. et al. (2011) J. Clin. Oncol. 29:3852.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Follistatin-like 5/FSTL5 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Follistatin-like 5/FSTL5 Protein, CF and earn rewards!
Have you used Recombinant Human Follistatin-like 5/FSTL5 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image